RESUMEN
No disponible
Asunto(s)
Adulto , Femenino , Humanos , Embarazo , Acceso a la Información , Servicios de Información sobre Medicamentos/normas , Comunicación en Salud/métodos , Educación del Paciente como Asunto/métodos , Educación del Paciente como Asunto/organización & administración , Analgesia Obstétrica/instrumentación , Analgesia Obstétrica/métodos , Analgesia Obstétrica , /métodos , Analgesia Obstétrica/ética , Analgesia Obstétrica/normas , Analgesia Obstétrica/tendencias , Tercer Trimestre del Embarazo , Tercer Trimestre del Embarazo/fisiología , Encuestas y CuestionariosAsunto(s)
Analgesia Epidural , Analgesia Obstétrica , Educación del Paciente como Asunto , Tercer Trimestre del Embarazo , Atención Prenatal , Adolescente , Adulto , Analgesia Epidural/psicología , Analgesia Obstétrica/psicología , Femenino , Humanos , Consentimiento Informado , Aceptación de la Atención de Salud , Embarazo , Embarazo de Alto Riesgo/psicología , Evaluación de Programas y Proyectos de Salud , Adulto JovenAsunto(s)
Anestésicos Generales/efectos adversos , Angioedema/inducido químicamente , Quimioterapia Combinada/efectos adversos , Hipotensión/inducido químicamente , Complicaciones Intraoperatorias/inducido químicamente , Enfermedad de Legg-Calve-Perthes/cirugía , Adulto , Combinación Amoxicilina-Clavulanato de Potasio/administración & dosificación , Combinación Amoxicilina-Clavulanato de Potasio/efectos adversos , Anestésicos Generales/administración & dosificación , Angioedema/fisiopatología , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/efectos adversos , Atracurio/administración & dosificación , Atracurio/efectos adversos , Atropina/administración & dosificación , Atropina/efectos adversos , Diclofenaco/administración & dosificación , Diclofenaco/efectos adversos , Síndrome de Down , Quimioterapia Combinada/administración & dosificación , Cara/fisiopatología , Fentanilo/administración & dosificación , Fentanilo/efectos adversos , Cadera/cirugía , Humanos , Enfermedad de Legg-Calve-Perthes/tratamiento farmacológico , Masculino , Midazolam/administración & dosificación , Midazolam/efectos adversos , Tiopental/administración & dosificación , Tiopental/efectos adversosRESUMEN
OBJECTIVE: To determine wether the physical status (ASA category) and surgical conditions could predict mortality in elderly general surgery patients. PATIENTS AND METHODS: This was a prospective study of patients greater than or equal 85 years of age who underwent elective or emergency surgery under general anesthesia between January 1987 and December 1991. Hospital mortality was defined as death occurring before discharge. Logical regression analysis (Cox's modeling) was used to assess group survival. RESULTS: One hundred and nine patients undergoing 117 operations were enrolled. Major surgery was performed in 70%; 44% were removals of malignant tumors and 84% were under general anesthesia. Hospital deaths occurred in 10%; the only significant predictors were neoplastic disease and emergency status. Mortality was 43% one year after surgery; significant predictors of death were prior physical status, neoplasia and emergency status. CONCLUSIONS: Neoplastic disease, emergency status and poor physical condition are factors that predict mortality in patients 85 or older who undergo general surgery.
Asunto(s)
Procedimientos Quirúrgicos Operativos/mortalidad , Anciano , Anciano de 80 o más Años , Urgencias Médicas , Femenino , Humanos , Tablas de Vida , Masculino , Neoplasias/mortalidad , Neoplasias/cirugía , Modelos de Riesgos Proporcionales , Estudios Prospectivos , Índice de Severidad de la Enfermedad , Análisis de SupervivenciaRESUMEN
Delayed pneumothorax may occur after subclavian vein catheterization and results from slow accumulation of air in the pleural space. Thus initial postinsertion chest x-rays may not detect this complication. The addition of positive pressure ventilation for general anaesthesia may make this complication life threatening. We report three cases and the literature is surveyed.
Asunto(s)
Cateterismo/efectos adversos , Neumotórax/etiología , Respiración con Presión Positiva/efectos adversos , Vena Subclavia , Anciano , Anestesia General/métodos , Femenino , Humanos , Persona de Mediana Edad , Factores de TiempoRESUMEN
Paraplegia after spinal anesthesia secondary to hematoma formation has been described. Many such reports have involved patients with a variety of coagulation disorders. This article describes a patient with clotting abnormalities, apparently due to chronic renal failure, who developed paraplegia after spinal anesthesia secondary to subarachnoid hematoma formation.
Asunto(s)
Anestesia Raquidea/efectos adversos , Fallo Renal Crónico/complicaciones , Paraplejía/etiología , Hematoma/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Hemorragia Subaracnoidea/complicacionesAsunto(s)
Anestesia General , Ketamina , Leucemia Linfoide/radioterapia , Femenino , Humanos , LactanteRESUMEN
To assess the prevalence of asymmetric septal hypertrophy (ASH) in hypertensive patients, 613 echocardiographic examinations performed over a period of one year were reviewed. Asymmetric septal hypertrophy (defined by an echocardiographic interventricular septum to left ventricular free wall thickness ratio of greater than or equal to 1.3 and by the presence of suggestive two-dimensional echocardiographic abnormalities) was found in 28 patients (5%). Clinical characteristics of asymmetric septal hypertrophy were assessed in 101 patients who underwent a complete evaluation. Patients with asymmetric septal hypertrophy (n = 9) were compared with patients with echocardiographic symmetrical left ventricle hypertrophy (n = 38) and without left ventricular hypertrophy (n = 54). Our results indicate that neither the severity of hypertension, nor the renin-angiotensin system nor sympathetic nerve activity appear to be the primary determinants in the development of asymmetric septal hypertrophy.